ME/CFS, myalgic encephalomyelitis, chronic fatigue syndrome, rehabilitation, integrated care, Post COVID Syndrome
myalgic encephalomyelitis, chronic fatigue syndrome, COVID-19, SARS-CoV-2, pandemic, post-COVID syndrome, immunoadsorption, plasmapheresis, autoantibodies
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID/Post-COVID Syndrome, Fibronectin (Fn1), Natural IgM Antibodies, Post-Viral Chronic Disease Biomarkers